Teva seeks stay after US court denies rehearing in Orange Book patent dispute
Teva Pharmaceuticals moved yesterday for a third stay in its patent suit against Amneal Pharmaceuticals, a day after the US Court of Appeals for the Federal Circuit denied Teva’s motion for...To view the full article, register now.
Already a subscriber? Click here to view full article